These results were not surprising given the fact that among patients with low hemoglobin, albumin, white blood cell count, lymph node metastases, and elevated preoperative tumor marker, the aggressive cancer (26, 27) and poor nutritional status (28–32) would predominantly worsen the survival outcome, whereas the prognostic effect of aging was not apparent. The gene discussed is ALB; the disease is cancer.